His Majesty's Treasury (HMT) has today announced the reappointment of Dr Vanessa Lawrence CB, Andrew Halford and Iain Mackay as Non-Executive Directors of UK Government Investments (UKGI).
His Majesty's Treasury (HMT) has today announced the reappointment of Dr Vanessa Lawrence CB, Andrew Halford and Iain Mackay as Non-Executive Directors of UK Government Investments (UKGI). They will remain as UKGI Board Members for the following terms: Vanessa Lawrence (26/09/2026-25/03/2029); Andrew Halford (17/10/2026-16/10/2029); Iain Mackay (01/11/2026-30/04/2030).
UKGI is the government's centre of expertise in corporate governance and corporate finance.
Vindi Banga, Chair of UKGI, said:
Andrew, Iain and Vanessa have all made significant contributions across the organisation, and I am delighted that they have been reappointed to the UKGI Board for a further term. I look forward to continuing to work with them, alongside the rest of the Board, as we support UKGI in delivering its strategy and HMG's wider objectives.
These reappointments are regulated by the Commissioner for Public appointments (OCPA) and made in accordance with the Governance Code on Public Appointments published by the Cabinet Office.
These reappointments are made on merit and political activity played no part in the decision process. In accordance with the code, there is a requirement for appointees' political activity (if any declared) to be made public. None of the reappointees had any political activity to declare.
Biographies
Vanessa was appointed Non-Executive Director of UK Government Investments in September 2023. She has more than 35 years' experience working in the digital data community and has a background in geographical information and space applications.
Andrew was appointed Non-Executive Director of UK Government Investments in October 2023. Andrew is currently Chief Financial Officer of Aareal Bank AG and Non-Executive Director of Relx.
Iain was appointed a Non-Executive Director of UK Government Investments in November 2023. Iain spent most of his career in senior finance leadership roles and retired as CFO of GSK plc in April 2023.
